MedPath

Study of Sildenafil in Patient With Heart Failure.

Phase 3
Completed
Conditions
Congestive Heart Failure
Registration Number
NCT00309816
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The purpose of this study is to determine if sildenafil (Viagra) improves exercise tolerance.

Detailed Description

Patients will undergo an exercise stress test. One dose of Sildenafil will then be given, followed by a one hour rest period. A repeat exercise stress test will then be repeated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

Age 18 - 75 Ejection fraction <35% Heart failure limited by fatigue and shortness of breath -

Exclusion Criteria

Inability to exercise. Patients with shortness of breath while resting. Patient requiring intravenous medication. Patients taking the following medications: nitroglycerine pill/patch/paste, isordil and Imdur

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Patients will have exercise capacity measured by an exercise stress test before and after one dose of sildenafil.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath